News Europe delays review of PTC's Duchenne drug Review of marketing authorisation delayed, new trial likely.
News How will Brexit affect rare disease research? The decision to leave the European Union is causing concern across all healthcare disciplines, with few answers to the many questions about where the UK will stand in relation to Europe.
Articles NICE and Highly Specialised Technologies: three years on Leela Barham examines the process for the appraisal of Highly Specialised Technologies.
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
